Alterations in endothelial cell proteinase and inhibitor polarized secretion following treatment with interleukin-1, phorbol ester, and human melanoma cell conditioned medium

Journal of Cellular Biochemistry

Volumn 60, Issue 1, 1996, Pages 148-160

  Cottam, David W ^a   Corbitt, Robert H ^a   Gomez, Daniel E ^a   Rees, Robert C ^b   Thorgeirsson, Unnur P ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c Office of the Director   (United States)

Author keywords

endothelium; IL 1 ; polarization; proteinases

Indexed keywords

METALLOPROTEINASE; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT INTERLEUKIN 1ALPHA; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MELANOMA; MEMBRANE DAMAGE; METASTASIS INHIBITION; PRIORITY JOURNAL;

ANIMALS; AORTA; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA, CONDITIONED; ENDOTHELIUM, VASCULAR; HAPLORHINI; HUMANS; INTERLEUKIN-1; MELANOMA; METALLOENDOPEPTIDASES; RECOMBINANT PROTEINS; TETRADECANOYLPHORBOL ACETATE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030039618     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19960101)60:1<148::AID-JCB17>3.0.CO;2-L     Document Type: Article

References (49)

1. Weiss L, Orr FW, Honn KV: Interactions between cancer cells and the microvasculature: A rate-regulator for metastasis. Clin Exp Metastasis 7:127-167, 1989.
2. McCarthy SA, Kuzu I, Gatter KC, Bicknell R: Heterogeneity of the endothelial cell and its role in organ preference of tumor metastasis. Trends Pharmacol Sci 12:462-467, 1991.
3. Zetter BR: The cellular basis of site-specific tumor metastasis. N Engl J Med 322:605-612, 1990.
4. Nicolson GL: Cancer metastasis: tumor cell and host organ properties important in metastasis to specific organ sites. Biochim Biophys Acta 948:175-224, 1988.
5. Dejana E, Bertocchi F, Bortolami MC, Regonesi A, Tonta A, Breviario F, Giavazzi R: Interleukin-1 promotes tumor cell adhesion to cultured human endothelial cells. Clin Invest 83:1466-1470, 1988.
6. Burrows FJ, Haskard DO, Hart IR, Marshall JF, Selkirk S, Poole S, Thorpe PE: Influence of tumor-derived interleukin 1 on melanoma-endothelial cell interactions. Cancer Res 51:4768-4775, 1991.
7. Bani MR, Garofalo A, Scanziani E, Giavazzi R: Effect of interleukin-1-beta on metastasis formation in different tumor systems. J Natl Cancer Inst 83:119-123, 1991.
8. Chirivi RGS, Garofalo A, Padura IM, Mantovani A, Giavazzi R: Interleukin-1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin-1 or lipopolysaccharide in a human melanoma/nude mouse system. Cancer Res 53:5051-5054, 1993.
9. Cottam DW, Rees RC: Regulation of matrix metalloproteinases: Their role in tumor invasion and metastasis (Review). Int J Oncol 2:861-872, 1993.
10. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P: A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704, 1990.
11. Stahle-Backdahl M, Parks WC: 92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am J Pathol 142:995-1000, 1993.
12. Montgomery AM, De Clerck YA, Langley KE, Reisfeld RA, Mueller BM: Melanoma-mediated dissolution of extracellular matrix: contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res 53:693-700, 1993.
13. Mignatti P, Tsuboi R, Robbins E, Rifkin DB: In vitro angiogenesis on the human amniotic membrane requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 108:671-682, 1989.
14. Vassalli JD, Sappino AP, Belin D: The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072, 1991.
15. Herron GH, Werb Z, Dwyer K, Banda MJ: Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenase and prostromelysin exceeds expression of proteolytic activity. J Biol Chem 261:2810-2813, 1986.
16. Kalebic T, Garbisa S, Glaser B, Liotta LA: Basement membrane collagen: Degradation by migrating endothelial cells. Science 221:281-283, 1983.
17. Herron GH, Banda MJ, Clark EJ, Gavriolovic I, Werb Z: Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem 261:2814-2818, 1986.
18. De Clerck YA, Yean TD, Ratzkin BJ, Lu HS, Langley KE: Purification and characterization of the related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 264:17445-17453, 1989.
19. Testa JE, Quigley JP: Reversal of misfortune: TIMP-2 inhibits tumor cell invasion. J Natl Cancer Inst 83:775-779, 1991.
20. Sporn LA, Marder VJ, Wagner DD: Inducible secretion of large, biologically potent von Willebrand factor multimers. Cell 46:185-190, 1986.
21. Gomez DE, Hartzler JL, Corbitt RH, Nason AM, Thorgeirsson UP: Immunomagnetic separation as a final purification step of liver endothelial cells. In Vitro Cell Dev Biol 29a:451-457, 1993.
22. Mackay AR, Ballin M, Pelina MD, Farina AR, Nason AM, Hartzler JL, Thorgeirsson UP: Effect of phorbol ester and cytokines on matrix metalloprateinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invas Metast 12:168-184, 1992.
23. LePrince P, Register B, Moonen G: A colorimetric assay for the simultaneous measurement of plasminogen activators and plasminogen activator inhibitors in serum-free conditioned media from cultured cells. Anal Biochem 177:341-346, 1989.
24. Mackay AR, Gomez DE, Cottam DW, Rees RC, Nason AM, Thorgeirsson UP: Identification of the 72 kDa (MMP-2) and 92 kDa (MMP-9) gelatinase/type IV collagenase in preparations of laminin and Matrigel™. Biotechniques 15:1048- 1051, 1993.
25. Towbin H, Staehlin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354, 1979.
26. Mackay AR, Corbitt RH, Hartzler JL, Thorgeirsson UP: Basement membrane type IV collagen degradation: Evidence for a proteolytic cascade independent of metalloproteinases. Cancer Res 50:5997-6000, 1990.
27. Kendall D, Lencer W, Matlin KS: Cryosectioning of epithelial cells grown on permeable supports. J Tissue Culture Methods 14:181-186, 1992.
28. Unemori EN, Bouhana KS, Werb Z: Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases and tissue inhibitor of metalloproteinases by endothelial cells. J Biol Chem 265:445-451, 1990.
29. van Hinsberg VW, van den Berg EA, Fiers W, Dooijewaard G: Tumor necrosis factor induces the production of urokinase type plasminogen activator by human endothelial cells. Blood 75:1991-1998, 1990.
30. Santell L, Levin EG: Cyclic AMP potentiates phorbol ester stimulation of tissue plasminogen activator release and inhibits secretion of plasminogen activator inhibitor-1 from human endothelial cells. J Biol Chem 263:16802-16808, 1988
31. Schleef RR, Wagner NV, Loskutoff DJ: Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells. J Cell Physiol 134:269-274, 1988.
32. Shapiro SD, Kobayashi DK, Welgus HG: Identification of TIMP-2 in human alveolar macrophages. Regulation of biosynthesis is opposite to that of metalloproteinases and TEMP-1. J Biol Chem 267-13890-13894, 1992.
33. Kronke M, Hensel G, Schluter C, Scheurich P, Schutze S, Pfizenmaier K: Tumor necrosis factor and lymphotoxin gene expression in human tumor cell lines. Cancer Res 48:5417-5421, 1988.
34. Bennicelli JL, Elias J, Kern J, Guerry D: Production of interleukin-1 activity by cultured human melanoma cells. Cancer Res 49:930-935, 1989.
35. Kock A, Schwarz T, Urbanski A, Peng Z, Vetterlein M, Micksche M, Ansel JC, Kung HF, Luger TA: Expression and release of interleukin-1 by different human melanoma cell lines. J Natl Cancer Inst 81:36-42, 1989.
36. Naylor MS, Stamp GWH, Balkwill FR: Investigation of cytokine gene expression in human colorectal cancer. Cancer Res 50:4436-4440, 1990.
37. Naylor MS, Malik STA, Stamp GWH, Jobling T, Balkwill FR: In situ detection of tumor necrosis factor in human ovarian cancer specimens. Eur J Cancer 26:1027-1030, 1990.
38. Rice GE, Gimbrone MA, Bevilacqua MP: Tumor cell-endothelial interactions. Increased adhesion of human melanoma cells to activated vascular endothelium. Am J Pathol 133:204-210, 1988.
39. Giavazzi R, Garofalo A, Bani MR, Abbate M, Ghezzi P, Boraschi D, Mantovani A, Dejana E: Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice. Cancer Res 50:4771-4775, 1990.
40. Mantovani A, Dejana E: Cytokines as communication signals between leukocytes and endothelial cells. Immunol Today 10:370-375, 1989.
41. Terranova VP, Maslow D, Markus G: Directed migration of murine and human tumor cells to collagenases and other proteases. Cancer Res 49:4835-1841, 1989.
42. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margulies IMK, Liotta LA: The activation of human type IV collagenase proenzyme. J Biol Chem 264:1353-1356, 1989.
43. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T: Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem 267:21712-21719, 1992.
44. Barroso M, Sztul ES: Basolateral to apical transcytosis in polarized cells is indirect and involves BFA and trimeric G protein sensitive passage through the apical endosome. J Cell Biol 124:83-100, 1993.
45. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267:10931-10934, 1992.
46. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23:755-761, 1992.
47. Flaumenhaft R, Rifkin DB: Extracellular matrix regulation of growth factor and protease activity. Curr Opin Cell Biol 3:817-823, 1991.
48. Hantai D, Festoff BW: Degradation of muscle basement membrane zone by locally generated plasmin. Exp Neurol 95:44-45, 1987.
49. Muller WA, Gimbrone MA Jr: Plasmalemmal proteins of cultured vascular endothelial cells exhibit apical-basal polarity: Analysis by surface-selective iodmation. J Cell Biol 103:2389-2402, 1986.